Our company

BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative formulation technology.
Our company focuses on the development of products for treatment of metabolic diseases and various immuno-therapies.



- WuXi STA and BioLingus sign exclusive technology and marketing collaboration for sublingual delivery,Feb 2019
- Biolingus receives Award for “Best European Biotech Company 2018”
- BioLingus proud winner of the 2018 Red Herring Top100 Award


APR 2019

2019 Global Venture Award
Biolingus wins the 2019 Global Venture Award.

APR 2018

2018 Red Herring Top 100 Award
Amsterdam, April 18th, 2018 : “BioLingus proud winner of the 2018 Red Herring Top 100 Award”
[Read More]



The Cytokine Stabilisation and Slow Release (CSSR) technology is the "mother" of the BioLingus technologies.


Through advanced "bio-engineering", the BioLingus SEED Technology is mimicking what is happening in nature in a plant SEED.


The OPUS (Oral Peptide Utility System) is our technology application to orally (sublingually) or via the mucosum administer peptides which have no immunomodulatory mode of action.


Due to the fact that BioLingus drug administration is sublingual, and the use of a specific carrier molecule in the BioLingus formulation, the BioLingus technology is particularly effective for sublingual immuno therapy.

Corporate Partnerships

Corporate Partnerships

To further exploit the potential of the BioLingus Technology, we are interested in exploring partnerships with other pharmaceutical companies. Aside from pharmaceutical companies, we are also interested in working with animal health companies" (with adjusted formulations) and food companies working on innovative food supplements.

Together we unlock the potential of the BioLingus Technology, and thus transform current standard practices in the administration of peptides and proteins.


Main Office
BioLingus AG

Grossmatt 6
CH-6052 Hergiswil NW